Patent Yard Sign in
Expired Canadian patentCanada

Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide

CA 1341240 C · Owner: Dainippon Sumitomo Pharma Co. Ltd. · Inventors: Notake, Mitsue; Furutani, Yasuji; Yamada, Masaaki

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A novel cloned DNA encoding a human tumor necrosis factor (TNF), a vector having said DNA inserted thereinto, a host transformed with said vector and a novel human TNF polypeptide, and processes for producing them.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted June 5, 2001. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 5, 2018.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 4, 1985
GrantedJune 5, 2001
Term endedJune 5, 2018
Patent numberCA 1341240 C
Classification (IPC)C12N15/28 +2 more

Timeline

Timeline From CIPO dates

198619901994199820022006201020142018Application filedMarch 4, 1985Patent grantedJune 5, 2001Term endedJune 5, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.